探索使用HBsAg来预测干扰素治疗过程,以实现慢性乙型肝炎患者的临床治愈:一项临床研究
Fei Yan1, Fei Tang2, Jing Chen1
1The Third Central Clinical College of Tianjin Medical University, Tianjin Third Central Hospital, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Institute of Hepatobiliary Disease, Tianjin, China.
Frontiers in immunology
|January 27, 2025
概括
一个新的模型预测了慢性乙型肝炎患者的干扰素治疗持续时间. 基线乙型肝炎表面抗原 (HBsAg) 水平是关键预测指标,使个性化治疗规划成为可能.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性乙型肝炎 (CHB) 管理需要优化基化干扰素α-2b (PEG-IFNα-2b) 治疗.
- 预测接受PEG-IFNα-2b的CHB患者的最佳治疗过程是一个重大的临床挑战.
研究的目的:
- 开发一种有效的预测模型,以确定CHB患者的最佳干扰素 (IFN) 治疗过程.
- 确定影响IFN治疗持续时间的关键因素,以实现个性化治疗.
主要方法:
- 招募了176名接受PEG-IFNα-2b单疗法或联合疗法的CHB患者.
- 随机划分为培训 (123名患者) 和验证 (53名患者) 队列.
- 单变量,多变量分析和外部验证以评估模型性能.
主要成果:
- 基线B型肝炎表面抗原 (HBsAg) 水平,12周的HBsAg和肝硬化存在是IFN治疗过程的显著预测因素.
- 经过调整后的分析证实HBsAg是一个显著的预测因子 (β=6.99,p<0.05).
- 开发的模型在验证队列中预测治疗持续时间方面表现出高准确性.
结论:
- 基线HBsAg水平是CHB中长期IFN治疗持续时间的重要风险因素.
- 使用基线HBsAg的个性化模型可以估计IFN治疗的持续时间,帮助临床决策.
更多相关视频
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


